Vall d'Hebron Institut de Recerca-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. REIV-TOXO Project: Results from a Spanish cohort of congenital toxoplasmosis (2015-2022). The beneficial effects of prenatal treatment on clinical outcomes of infected newborns

    PLoS neglected tropical diseases, Vol. 18, Núm. 10, pp. e0012619

  2. Renal Function Impairment in Children With Congenital Cytomegalovirus Infection: A Cross-sectional Study

    The Pediatric infectious disease journal, Vol. 43, Núm. 3, pp. 257-262

  3. Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study

    Clinical Infectious Diseases, Vol. 79, Núm. 1, pp. 215-222

2023

  1. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2021

  1. Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old

    European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2099-2106

  2. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

    Journal of Pediatrics, Vol. 236, pp. 211-218.e2

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

2019

  1. Is Polymerase Chain Reaction in Neonatal Dried Blood Spots Reliable for the Diagnosis of Congenital Cytomegalovirus Infection?

    The Pediatric infectious disease journal, Vol. 38, Núm. 5, pp. 520-524

  2. Role of magnetic resonance imaging and cranial ultrasonography in congenital cytomegalovirus infection

    Pediatric Infectious Disease Journal, Vol. 38, Núm. 11, pp. 1131-1137